Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Family Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Cardiologist
M.B.B.S., F.C.P.S., MRCP
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Gastroenterologist
M.B.B.S., M.R.C.P (UK), F.R.C.P (UK), CCST GASTROENTEROLOGY/HEPATOLOGY/GENERAL MEDICINE
Gastroenterologist
M.B.B.S., M.R.C.P (UK), F.R.C.P (UK), CCST GASTROENTEROLOGY/HEPATOLOGY/GENERAL MEDICINE
General Physician
M.B.B.S., F.C.P.S., Certified in ESE
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures